Unaccounted for social and clinical characteristics of a hospital's patient population explain nearly half of the difference in readmission rates between the best and the worst performing hospitals when it comes to Medicare penalties for hospital readmission rates.
Unaccounted for social and clinical characteristics of a hospital's patient population explain nearly half of the difference in readmission rates between the best and the worst performing hospitals when it comes to Medicare penalties for hospital readmission rates, according to a study published in JAMA Internal Medicine.
assessed 29 patient characteristics as potential predictors of 30-day readmission.
using survey data from the Health and Retirement Study and linked claims for those participants enrolled in Medicare who were hospitalized from 2009 to 2012. In addition, they
assessed the extent to which patient characteristics account for differences in hospital readmission rates by
Researchers from Harvard Medical School
of hospital readmission rates
he difference in the probability of readmission between participants admitted to hospitals in the highest vs lowest quintile of hospital-wide readmission rates was reduced by 48% from 4.41 percentage points to 2.29 percentage points.
assessed, 22 significantly predicted readmission beyond standard Medicare adjustments . After adjusting for these patient characteristics, t
Of the patient characteristics
Patient characteristics not included in Medicare’s current risk-adjustment methods explained much of the difference in readmission risk between patients admitted to hospitals with higher vs lower readmission rates," the authors determined.
As such, penalties for hospitals with high readmission rates, may be based, to a large extent, simply on the patient population they serve.
Read the article: http://bit.ly/1MmPcWX
"
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More